Biota Holdings Set for Nasdaq Listing Following Merger – Wall Street Journal (blog)
|
Biota Holdings Set for Nasdaq Listing Following Merger
Wall Street Journal (blog) By Gavin Lower and Gillian Tan AP Australian drug development company Biota Holdings said Monday it plans to merge with Nabi Biopharmaceuticals to form a combined company to be listed on the Nasdaq. Based on Biota's currently traded price of 88 … Australia's Biota, Nabi to merge, list on Nasdaq Biota to merge with Nabi and list on Nasdaq for better capital access Biota to merge with US company |
